Delivery Order HHSN261201600005I-HHSN26100001

<p>This is a Delivery Order award to Miedzynarodowy Instytut Onkologii Molekularnej, a foundation-type vendor, by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute. The $144,300.00 Firm Fixed Price contract is for Tissue Source Site for Tumor Analysis services, under a parent Master IDIQ vehicle. The place of performance is in Poland, and the completion date was September 16, 2020. No set-aside was used for this award.</p>

This is a firm-fixed-price delivery order awarded by the National Cancer Institute (NCI) to Miedzynarodowy Instytut Onkologii Molekularnej, a foundation located in Poland. The contract is for Tissue Source Site (TSS) services in support of NCI's Clinical Proteomic Tumor Analysis Consortium, specifically for the analysis of 100 cases across Payments 1-3 at a rate of $2,000 per case (with an 85% payment factor). The total ceiling value of the contract is $402,700. This delivery order is part of...

The National Cancer Institute (NCI) awarded a $71,250.00 Firm Fixed Price Delivery Order to the Miedzynarodowy Instytut Onkologii Molekularnej, a foundation located in Poland, for medical images of biospecimens under the Tissue Source Site for Tumor Analysis contract vehicle. The work is part of the NCI's CPTAC (Clinical Proteomic Tumor Analysis Consortium) program, which focuses on generating and analyzing comprehensive clinical proteomic data for cancer research. This contract does not have...

This is a firm-fixed-price delivery order awarded by the National Cancer Institute (NCI) to Wielkopolskie Centrum Onkologii IM Marii Sklodowskiej Curie (Centrum Onkologii) in Poland. The contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ, with a ceiling value of $336,000.00 and a period of performance ending on September 30, 2014. The contract is for the provision of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA)...

This is a Delivery Order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Melanoma Institute Australia, a foreign-owned non-profit organization. The contract is for $192,500.00 and is related to the NCI Cancer Genome Atlas Program, which involves the collection of tissue samples and data from various types of cancer. There is no set-aside designation for this contract. The contract is a Firm Fixed Price type and has an ultimate completion date of September 30, 2014....

This $17,053.58 firm fixed price purchase order was awarded by the National Cancer Institute (NCI), a civilian agency, to an undisclosed prime contractor on September 11, 2024. The contract is for a service agreement with a period of performance through March 10, 2025. No set-aside designation is indicated. The contract award does not provide details about the specific products or services to be delivered, but as the NCI is the funding agency, the work is likely related to the institute's cancer...

This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Istituto Superiore DI Sanita' - ISS, a foreign government entity in Italy. The contract, valued at $79,994.00, is for extending code and methods to provide estimates by phases of care (MIAMOD/PIAMOD). The contract does not have a set-aside designation and the ultimate completion date is February 28, 2018. ISS has...

<p>This is a $632,469.60 firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Biopartners, Inc. The contract supports the Tissue Source Site for Tumor Analysis program and has a final completion date of September 4, 2021. There was no set-aside designation for this award. The contract does not mention any major subcontractors.</p>

This is a $884,040.57 firm fixed price delivery order contract awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract is for the acquisition of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. The contract was awarded to Indivumed, Inc., a for-profit organization, and is not set aside for any special designation. The contract is a delivery order under the NCI Cancer...

<p>This is a $16,000.00 federal purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Liliya Starastsenka, a for-profit organization located in Belarus. The contract is for the delivery of DATASETS FOR ANALYSIS, as described in the government's contract description. The contract has a firm fixed price pricing type and an ultimate completion date of March 3, 2026. This contract award was not set-aside for any special program.</p>